Drägerwerk AG & Co. KGaA (pref)

Research Drägerwerk AG & Co. KGaA (pref) (DRW3) on Bullrun: valuation model: 59.8% undervalued, market cap EUR 1.44B, P/E 9.4, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Drägerwerk AG & Co. KGaA (pref) as 59.8% undervalued; latest market cap is EUR 1.44B; P/E is 9.4; dividend yield is 2.7%.

About Drägerwerk AG & Co. KGaA (pref)

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine.

Frequently asked questions

Is Drägerwerk AG & Co. KGaA (pref) overvalued or undervalued?

Bullrun's valuation model currently marks Drägerwerk AG & Co. KGaA (pref) as 59.8% undervalued.

What is Drägerwerk AG & Co. KGaA (pref)'s market cap?

Drägerwerk AG & Co. KGaA (pref)'s market capitalization is EUR 1.44B.

What is Drägerwerk AG & Co. KGaA (pref)'s P/E ratio?

Drägerwerk AG & Co. KGaA (pref)'s price-to-earnings (P/E) ratio is 9.4.

Does Drägerwerk AG & Co. KGaA (pref) pay a dividend?

Drägerwerk AG & Co. KGaA (pref) has a dividend yield of 2.7%.

What does Drägerwerk AG & Co. KGaA (pref) do?

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine.